💊 Green Tea Extract (EGCG) Cancer Research

Green tea extract, particularly its active component EGCG (epigallocatechin gallate), has emerged as a subject of significant interest in cancer research. This powerful catechin—a type of polyphenol found naturally in green tea leaves—has demonstrated noteworthy anti-cancer properties in laboratory and animal studies over the past two decades. Researchers have investigated how EGCG may interfere with cancer cell growth, induce apoptosis (programmed cell death), and potentially enhance the effectiveness of conventional cancer treatments.

The scientific interest in green tea extract stems from epidemiological observations and mechanistic studies suggesting that regular green tea consumption may be associated with lower cancer incidence in certain populations. These findings have prompted rigorous investigation into how EGCG works at the cellular and molecular level, including its effects on cell signaling pathways, antioxidant activity, and interactions with cancer-promoting processes. While results from laboratory studies are promising, clinical research in humans is still evolving, with several ongoing trials examining optimal dosing, bioavailability, and real-world effectiveness as both a preventive supplement and complementary approach.

On this page, you'll find the latest peer-reviewed research articles examining green tea extract and EGCG in cancer contexts. These resources are designed to help patients, caregivers, and healthcare providers understand current scientific evidence, including what studies show, remaining questions, and how this research fits into broader cancer prevention and treatment strategies.